Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis

Table 2 Clinical data obtained during the hospital stay

Variable	n = 22
Systemic antibiotic treatment during hospital stay, n (%)	21/22 (95.5)
Duration of IV steroid therapy prior to start of tacrolimus therapy (mean ± SEM)	6.7 ± 0.7
Use of parenteral nutrition during hospital stay, n (%)	9/22 (40.9)
Blood transfusion during hospital stay, n (%)	10/22 (45.5)
Oral mesalamine therapy during hospital stay, n (%)	17/22 (77.3)
Stay in intermediate care unit during part of the hospitalization, n (%)	4/22 (18.2)
Duration of hospital stay, d (mean ± SEM)	22.8 ± 4.9
Addition of a second immunosuppressive as a maintenance therapy during hospital stay, n (%)	10/22 (45.5)
Anti-integrin (vedolizumab)	5/22 (22.7)
Thiopurine (azathioprine or 6-mercaptopurine)	5/22 (22.7)

SEM: Standard error of the mean; IV: Intravenous.